• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型降低吖啶结构小分子抗菌剂的合成与抗菌活性评价,包括对包括 MRSA 在内的 菌株的抗菌活性。

Synthesis and Antibacterial Evaluation of Novel Small-Molecule Antibacterials of a Reduced Acridine Structure in Strains Including MRSA.

机构信息

Institute of Pharmacy, Martin-Luther-University Halle-Wittenberg, Wolfgang-Langenbeck-Str. 4, 06120 Halle, Germany.

Department of Medical Microbiology, University of Szeged, Dóm tér 10, 6720 Szeged, Hungary.

出版信息

Med Chem. 2024;20(8):831-838. doi: 10.2174/0115734064302048240424045239.

DOI:10.2174/0115734064302048240424045239
PMID:38726790
Abstract

BACKGROUND

The increasing antibacterial drug resistance remains a threat to global health with increasing mortality and morbidity. There is an urgent need to find novel antibacterials and develop alternative strategies to combat the increasing antibacterial drug resistance.

OBJECTIVE

We aimed to synthesize novel small-molecule antibacterials to evaluate the structuredependent antibacterial compound activities against S. aureus and MRSA.

METHODS

Compounds were synthesized by primary N-alkylation to form alkyl acridinium salts that were further functionalized with substituted phenyl residues and finally purified by column chromatography. The antibacterial growth inhibition activity was determined as MIC value.

RESULTS

The substituent effects on the determined antibacterial growth inhibitory properties have been discussed.

CONCLUSION

The best activities have been found for compounds with methoxy functions, exceeding the activities of reported novel antibacterial peptides. The compounds have also shown antibacterial drug-enhancing effects, which have been manifested as a reduction in the MIC values of the used antibiotics.

摘要

背景

抗菌药物耐药性不断增加,导致死亡率和发病率上升,对全球健康构成威胁。因此迫切需要寻找新型抗菌药物并开发替代策略来应对日益增加的抗菌药物耐药性。

目的

我们旨在合成新型小分子抗菌药物,以评估结构依赖性抗菌化合物对金黄色葡萄球菌和耐甲氧西林金黄色葡萄球菌的活性。

方法

通过初级 N-烷基化合成烷基吖啶盐,然后用取代的苯基残基进一步官能化,最后通过柱层析进行纯化。抗菌生长抑制活性通过 MIC 值确定。

结果

讨论了取代基对确定的抗菌生长抑制特性的影响。

结论

发现具有甲氧基功能的化合物具有最佳活性,超过了报道的新型抗菌肽的活性。这些化合物还表现出抗菌药物增强作用,表现为所用抗生素的 MIC 值降低。

相似文献

1
Synthesis and Antibacterial Evaluation of Novel Small-Molecule Antibacterials of a Reduced Acridine Structure in Strains Including MRSA.新型降低吖啶结构小分子抗菌剂的合成与抗菌活性评价,包括对包括 MRSA 在内的 菌株的抗菌活性。
Med Chem. 2024;20(8):831-838. doi: 10.2174/0115734064302048240424045239.
2
Discovery of a novel class of small-molecule antibacterial agents against .发现一类针对 的新型小分子抗菌剂。
Future Med Chem. 2022 Mar;14(5):299-305. doi: 10.4155/fmc-2021-0272. Epub 2021 Dec 24.
3
Novel Small-Molecule Hybrid-Antibacterial Agents against and MRSA Strains.新型小分子杂合抗菌剂对抗 和耐甲氧西林金黄色葡萄球菌菌株。
Molecules. 2021 Dec 23;27(1):61. doi: 10.3390/molecules27010061.
4
Antibacterial Small Molecules That Potently Inhibit Staphylococcus aureus Lipoteichoic Acid Biosynthesis.强效抑制金黄色葡萄球菌脂磷壁酸生物合成的抗菌小分子。
ChemMedChem. 2019 May 17;14(10):1000-1004. doi: 10.1002/cmdc.201900053. Epub 2019 Apr 30.
5
Synthesis, Molecular Docking Studies and Antibacterial Activities of Novel Monocationic Indole-benzimidazole Derivatives.新型单阳离子吲哚-苯并咪唑衍生物的合成、分子对接研究及抗菌活性
Med Chem. 2021;17(7):699-706. doi: 10.2174/1573406416666200420080459.
6
Antibacterial activity of novel benzopolycyclic amines.新型苯并多环胺的抗菌活性
Bioorg Med Chem. 2015 Jan 15;23(2):290-6. doi: 10.1016/j.bmc.2014.11.041. Epub 2014 Dec 3.
7
Structure-activity relationships of pyrazole-4-carbodithioates as antibacterials against methicillin-resistant Staphylococcus aureus.吡唑-4-碳二硫代酸酯作为抗耐甲氧西林金黄色葡萄球菌抗菌剂的构效关系
Bioorg Med Chem Lett. 2018 Dec 1;28(22):3526-3528. doi: 10.1016/j.bmcl.2018.09.038. Epub 2018 Oct 3.
8
Discovery of bisindolyl-substituted cycloalkane-anellated indoles as novel class of antibacterial agents against S. aureus and MRSA.发现双吲哚基取代的环烷并吲哚作为一类新型抗金黄色葡萄球菌和耐甲氧西林金黄色葡萄球菌的抗菌剂。
Bioorg Med Chem Lett. 2016 Jan 1;26(1):218-21. doi: 10.1016/j.bmcl.2015.10.085. Epub 2015 Oct 29.
9
Novel effective antibacterial small-molecules against and strains.新型有效抗菌小分子对 和 株的作用。
Future Med Chem. 2020 Jul;12(13):1205-1211. doi: 10.4155/fmc-2020-0010. Epub 2020 Jun 9.
10
Design, Synthesis, and Antibacterial Evaluation of Novel Ocotillol Derivatives and Their Synergistic Effects with Conventional Antibiotics.新型欧前胡醇衍生物的设计、合成及抗菌活性评价及其与传统抗生素的协同作用。
Molecules. 2021 Oct 1;26(19):5969. doi: 10.3390/molecules26195969.

本文引用的文献

1
Design and Synthesis of Novel Antimicrobial Agents.新型抗菌剂的设计与合成
Antibiotics (Basel). 2023 Mar 22;12(3):628. doi: 10.3390/antibiotics12030628.
2
Intermittent antibiotic treatment of bacterial biofilms favors the rapid evolution of resistance.间歇性抗生素处理细菌生物膜有利于耐药性的快速进化。
Commun Biol. 2023 Mar 16;6(1):275. doi: 10.1038/s42003-023-04601-y.
3
Regulation of Virulence and Application of Nanotherapeutics to Eradicate Infection.毒力调控与纳米治疗在根除感染中的应用
Pharmaceutics. 2023 Jan 17;15(2):310. doi: 10.3390/pharmaceutics15020310.
4
Acridine as an Anti-Tumour Agent: A Critical Review.吖啶作为一种抗肿瘤药物:一项批判性评价。
Molecules. 2022 Dec 26;28(1):193. doi: 10.3390/molecules28010193.
5
Acridine and Its Derivatives: Synthesis, Biological, and Anticorrosion Properties.吖啶及其衍生物:合成、生物学及防腐性能
Materials (Basel). 2022 Oct 28;15(21):7560. doi: 10.3390/ma15217560.
6
Production of biofilm by Staphylococcus aureus: Association with infective endocarditis?金黄色葡萄球菌生物膜的产生:与感染性心内膜炎有关吗?
Enferm Infecc Microbiol Clin (Engl Ed). 2022 Oct;40(8):418-422. doi: 10.1016/j.eimce.2021.03.009.
7
Mechanisms of antibiotic action shape the fitness landscapes of resistance mutations.抗生素作用机制塑造了耐药性突变的适应度景观。
Comput Struct Biotechnol J. 2022 Aug 24;20:4688-4703. doi: 10.1016/j.csbj.2022.08.030. eCollection 2022.
8
Antimicrobial Activity Enhancers: Towards Smart Delivery of Antimicrobial Agents.抗菌活性增强剂:迈向抗菌剂的智能递送
Antibiotics (Basel). 2022 Mar 18;11(3):412. doi: 10.3390/antibiotics11030412.
9
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.2019 年全球细菌对抗菌药物耐药性的负担:系统分析。
Lancet. 2022 Feb 12;399(10325):629-655. doi: 10.1016/S0140-6736(21)02724-0. Epub 2022 Jan 19.
10
Nanotechnology-Based Delivery Systems for Antimicrobial Peptides.基于纳米技术的抗菌肽递送系统
Pharmaceutics. 2021 Oct 26;13(11):1795. doi: 10.3390/pharmaceutics13111795.